People · Operator
Named in public records as an officer, director or promoter · active 2012–2020 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Flame Biosciences, Inc. | — | Biotechnology | Series D+ | $108.5M | $3.8B | 2020 |
| ControlRad, Inc. | — | Other Health Care | Series A | $40.7M | $10.8M | 2012 |
Harlan Weisman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Harlan Weisman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ryan Drant | 1 | 24 |
| David Barrett | 1 | 13 |
| Robert Stein | 1 | 6 |
| TIM OPLER | 1 | 6 |
| Mark Simon | 1 | 6 |
| David Shulkin | 1 | 5 |
| Steven Nichtberger | 1 | 3 |
| Paul Mirabella | 1 | 3 |
| Justin Kirkpatrick | 1 | 2 |
| GUILLAUME BAILLIARD | 1 | 1 |
| George Avgerinos | 1 | 1 |
| Pamela Demain | 1 | 1 |
| George Avgerino | 1 | 1 |
| Leonid Gorelik | 1 | 1 |
| Haim Melman | 1 | 1 |
| Opler Tim | 1 | 1 |
| Amir Yaron | 1 | 1 |
| Allon Guez | 1 | 1 |
| TIM PATRICK | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.